Laurent Audoly PhD

Laurent has led pharma and biotech R&D organizations in the U.S. and EU for more than 20 years, discovering and developing novel medicines, including five approved drugs (both small and large molecule) in inflammation, dermatology, cardiovascular diseases, and oncology. Prior to joining Kymera, Laurent was the head of R&D at Pierre Fabre, an EU-based pharmaceutical company with more than $2.5B in revenues. During his tenure there, he championed the in- and out-licensing of numerous clinical-stage assets and technologies, and directly contributed to IND entries and POC and LCM studies in oncology, dermatology, and neuropsychiatry. He has also held leadership positions at Pfizer, Merck, MedImmune and Pieris.
Laurent earned his PhD in pharmacology at Vanderbilt University, and did his post-doctoral training at Duke University where he was awarded a fellowship from the American Heart Association. Laurent is a co-author on more than 70 peer-reviewed publications and patents and has served on various NIH study sections. He serves as a board member and advisor for multiple healthcare organizations worldwide to help accelerate the discovery and advancement of novel therapies for patients and their families.